secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001628280-25-007716
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

agilon health Q4 revenue up 44% to $1.52B; net loss narrows to $106M; guides 2025 EBITDA loss improvement
--------------------------------------------------------------------------------

- Q4 revenue $1.52B (+44% YoY); full-year revenue $6.06B (+40%). Medicare Advantage members 527,000 (+36%).
- Q4 net loss $106M (vs $230M loss in Q4 2023); full-year net loss $260M (vs $263M). Adjusted EBITDA loss $84M (Q4) and $154M (FY).
- Medical margin improved to $1M in Q4 from negative $102M; FY medical margin $205M vs $299M. Gross profit negative $38M.
- 2025 guidance: revenue $5.825-6.025B; medical margin $275-325M; Adjusted EBITDA loss $95-55M. Expects elevated cost trend of 6.3% (gross) vs 6.8% in 2024.
- Exiting partnerships affecting ~54,000 members; Class of 2025 adds ~20,000 MA members. Part D exposure reduced to <30%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000162828025007716/0001628280-25-007716-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000162828025007716/agl-20250225.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-007716

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer